Technology group Microsaic Systems has signed a pre-contract commercial agreement to provide its Microsaic 4000 MiD spectrometer as an original equipment manufacturer (OEM).

The agreement, for the global, exclusive marketing and sale of the 4000 MiD for use in protein separation applications, has been signed with an unnamed "major international healthcare equipment company", Microsaic said.

The company and its partner are now working towards completion and signing of a full commercial contract by the end of 2014. The contract is expected to include a commitment to purchase up to 50 units and consumables of the 4000 MiD in the first year, increasing to over 200 units and consumables from the fourth year onwards.

"We are delighted to begin this new OEM relationship with one of the leading global suppliers of healthcare instrumentation," said Chief Executive Colin Jump.

"This relationship will introduce a substantial new market segment for Microsaic. We believe that our unique 4000 MiD system has the potential to make mass spectrometry more accessible to lab scientists than ever before, thereby opening up new opportunities across a wide range of applications and formats."

The stock was up 5.4% at 45.32p on Monday afternoon.

BC

Related share prices
() share price
() share price
() share price
() share price
D (D) share price
S (S) share price
() share price
() share price